On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Azienda Sanitaria Locale Viterbo

InstitutionResearch output, impact & collaborations

Azienda Sanitaria Locale Viterbo is a institution indexed in ScholarIQ from OpenAlex.

What is known about Azienda Sanitaria Locale Viterbo?

ScholarIQrecord summary

Azienda Sanitaria Locale Viterbo is a research organisation in Viterbo, IT. OpenAlex records 2,773 works and 30,318 citations for it. 389 researchers list it as their most recent affiliation.

How many works does Azienda Sanitaria Locale Viterbo have?

ScholarIQindexed works

Azienda Sanitaria Locale Viterbo has 2,773 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Azienda Sanitaria Locale Viterbo have?

ScholarIQcitation count

Azienda Sanitaria Locale Viterbo has 30,318 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Azienda Sanitaria Locale Viterbo?

ScholarIQresearcher count

Azienda Sanitaria Locale Viterbo has 389 researchers in the ScholarIQ index.

What is the average h-index at Azienda Sanitaria Locale Viterbo?

ScholarIQavg h-index

Azienda Sanitaria Locale Viterbo has an average h-index of 18 in OpenAlex.

What is the ROR of Azienda Sanitaria Locale Viterbo?

ScholarIQror

The ROR for Azienda Sanitaria Locale Viterbo is on the source record.

What is the OpenAlex record for Azienda Sanitaria Locale Viterbo?

ScholarIQopenalex

The OpenAlex for Azienda Sanitaria Locale Viterbo is on the source record.

Who are the most-cited researchers behind Azienda Sanitaria Locale Viterbo?

ScholarIQtop researchers by citations
1
Pietro De Luca · Vestibular and auditory disorders
176 works1,456 citations

What are the most-cited papers on Azienda Sanitaria Locale Viterbo?

ScholarIQmost cited works
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combinedwith Olfactory Training to Treat Post-COVID-19 OlfactoryImpairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial
Arianna Di Stadio, Luca D’Ascanio, Luigi Angelo Vaira, Elena Cantone, Pietro De Luca, Cristina Cingolani, Gaetano Motta, Giacomo De Riu, Federica Vitelli, Giuseppe Spriano, Marco de Vincentiis, Angelo Camaioni, Ignazio La Mantia, Fabio Ferreli, Michael Brenner
Current Neuropharmacology. 2022109 CitationsOPEN ACCESS
Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder
Virginia L. Misener, Pietro De Luca, O Azeke, Jennifer Crosbie, Irwin D. Waldman, Rosemary Tannock, Wendy Roberts, Molly Malone, Russell Schachar, Abel Ickowicz, James L. Kennedy, Cathy L. Barr
Molecular Psychiatry. 2003102 Citations
Biomarkers of laryngeal squamous cell carcinoma: a review
Matteo Cavaliere, A. Bisogno, Alfonso Scarpa, Alessia D'Urso, Pasquale Marra, Vito Colacurcio, Pietro De Luca, Massimo Ralli, Ettore Cassandro, Claudia Cassandro
Annals of Diagnostic Pathology. 202176 Citations
Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study
Pietro De Luca, Angelo Camaioni, Pasquale Marra, Giovanni Salzano, Giovanni Carriere, Luca Ricciardi, Resi Pucci, Nicola Montemurro, Michael Brenner, Arianna Di Stadio
Cells. 202274 CitationsOPEN ACCESS
Hearing Loss and Cognitive Impairment: Epidemiology, Common Pathophysiological Findings, and Treatment Considerations
A. Bisogno, Alfonso Scarpa, Stefano Di Girolamo, Pietro De Luca, Claudia Cassandro, Pasquale Viola, Filippo Ricciardiello, Antonio Greco, Marco de Vincentiis, Massimo Ralli, Arianna Di Stadio
Life. 202162 CitationsOPEN ACCESS

How much of the research on Azienda Sanitaria Locale Viterbo is open access?

ScholarIQopen access share
64%OPEN ACCESS
Gold
45%
Green
0%
Hybrid
0%
Bronze
18%
Closed
36%

Related on ScholarIQ

470M+ articles · 14-day free trial